-
Mashup Score: 15Contemporary neighborhood redlining and racial mortgage lending bias and disparities in prostate cancer survival - 4 day(s) ago
Residing in a more contemporary redlined neighborhood (location-based mortgage discrimination) was associated with an increased risk of all-cause mortality among Black and White men diagnosed with pr…
Categories: General Medicine NewsTweet
-
Mashup Score: 9
Dr. Chu highlights how PSMA PET is transforming perioperative prostate cancer care, including improving surgical precision.
Source: www.guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
📺 @CChuMD of @UCSFUrology details her presentation at the 2025 PSMA and Beyond Conference on the role of PSMA PET in surgical planning and post-operative management. 🔎 Learn how PSMA PET is transforming perioperative #prostatecancer care: https://t.co/wq8xpTa6HA https://t.co/J8RFxWYF77
-
-
Mashup Score: 1Bupa covers accurate PSE prostate cancer blood test - 5 day(s) ago
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Source: www.urologynews.uk.comCategories: General Medicine News, UrologyTweet-
RT @DrBartu: Read about us in Urology News (@Uro_News): @Bupa covers accurate #ProstateCancer blood test: https://t.co/sEM2yAQ8cA
-
-
Mashup Score: 1Case-Based Discussion on Navigating the Evolving Landscape of Castrate-Resistant Prostate Cancer Management - Oliver Sartor - 10 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: A. Oliver Sartor, MD, Professor of Medicine, Urology, and Radiology, Director Radiopharmaceutical Trials, Mayo Clinic, Rochester, MN Rana McKay, MD , Medical Oncologist, Associate Professor of…
Source: www.urotoday.comCategories: General Medicine News, UrologyTweet-
Case-based discussion on navigating the evolving landscape of castrate-resistant #ProstateCancer management. Oliver Sartor, MD @MayoClinic joins @DrRanaMcKay @UCSanDiego as part of an independent medical education initiative on UroToday > https://t.co/ygi8XDjAQC @BayerPharma https://t.co/OZG83QZgbB
-
-
Mashup Score: 6The Use of Radioligand Treatments in Metastatic Castration-Resistant Prostate Cancer - Matthew Abramowitz - 10 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer. This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Matthew Abramowitz, MD, Associate Professor, Department of Radiation Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL Rana McKay, MD , Medical Oncologist, Associate…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
The use of radioligand treatments in metastatic castration-resistant #ProstateCancer. Matthew Abramowitz, MD @SylvesterCancer joins @DrRanaMcKay @UCSanDiego to discuss as part of this Independent Medical Education Initiative on UroToday > https://t.co/X84or9D8N4 @BayerPharma https://t.co/bFzTwblrXZ
-
-
Mashup Score: 1Collection Details : Oncology Times - 11 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine NewsTweet-
Koji Hatano, MD, reported differences between the several key microbial species in the gut microbiomes of patients with metastatic #ProstateCancer that distinguished them from those with non-metastatic disease. Listen to the podcast: https://t.co/Uwy1UQrxF5. https://t.co/1znTBXIvRZ
-
-
Mashup Score: 0Evaluating Safety and Efficacy of PSMA Therapy in the Castration-Sensitive Setting | GU Oncology Now - 12 day(s) ago
Dr. Morris discusses trials and rationale behind using PSMA therapy earlier in prostate cancer treatment.
Source: www.guoncologynow.comCategories: General Medicine News, Partners & KOLsTweet-
📺 At the PSMA & Beyond Conference, Dr. Michael Morris of @MSKCancerCenter explored the rationale behind moving PSMA-targeted RLT into the castration-sensitive setting for #prostatecancer: https://t.co/B2iLbnaZty 🔎 Dr. Morris outlines the philosophical and clinical case for https://t.co/Z4Q367NuKw
-
-
Mashup Score: 13PSMA PET Imaging and Targeted Therapies: A Case Study on High-Risk Localized Prostate Cancer - Tian Zhang - 14 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Tian Zhang, MD, MHS, Associate Professor, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
PSMA PET imaging and targeted therapies: a case study on high-risk localized #ProstateCancer. @TiansterZhang @UTSWNews and @Ecastromarcos discuss in this Independent Medical Education Initiative on UroToday > https://t.co/k242D9ESRr @BayerPharma https://t.co/d7RoO3stOp
-
-
Mashup Score: 3Collection Details : Oncology Times - 15 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine NewsTweet-
A numerical formula combining risk factors is being used to select patients whose intermediate risk #ProstateCancer can safely be followed with active surveillance. Ruben Del Castillo, MD, discusses the study results. https://t.co/3JSvxPpgnv. https://t.co/sru1M4e8YC
-
-
Mashup Score: 27Real-World Evidence Informs Clinical Decision-Making in Metastatic Castration-Resistant Prostate Cancer - Alan Bryce - 16 day(s) ago
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Alan Bryce, MD, Chief Clinical Officer, City of Hope Cancer Center Pheonix, Phoenix, Arizona Elena Castro, MD, PhD, Hospital Universitario 12 de Octubre, Madrid, Spain Related Content: An Overview in…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Real-world evidence informs clinical decision-making in metastatic castration-resistant #ProstateCancer. @AlanBryce9 @cityofhope joins @Ecastromarcos in this discussion as part of an Independent Medical Education Initiative supported by @BayerPharma > https://t.co/W3eCflNlhO https://t.co/wivvWqyWuf
-
Contemporary redlining was associated with poorer #ProstateCancer (PC) survival in the overall population. Findings suggest that mortgage lending discrimination may contribute to disparities in PC survival. https://t.co/ktRlLRdQIt @OncoAlert @jkmcgee @APLoehrer @meredithshiels https://t.co/T41KATxm0X